Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDK69
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $148,348
Award facts
- Contract value 100% obligated
- $148,347.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $148,347.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on July 23, 2025, is scheduled for ultimate completion by August 13, 2025, with performance taking place at the contractor's Park Ridge facility. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace based on its qualifications and pricing.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The parent IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Entyvio, a biologic medication used for inflammatory bowel disease treatment, represents one of the specialized pharmaceutical products within this broader supply arrangement that supports the Department of Defense's healthcare requirements across its medical facilities globally.
Quick answers
Who was awarded contract SPE2DB25FDK69?
SPE2DB25FDK69 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FDK69 worth?
The government has obligated $148,348 on SPE2DB25FDK69.
Is contract SPE2DB25FDK69 an order under another contract?
Yes. SPE2DB25FDK69 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK69 competed?
The extent of competition for SPE2DB25FDK69 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award